GB0909792D0 - Composition and uses thereof - Google Patents

Composition and uses thereof

Info

Publication number
GB0909792D0
GB0909792D0 GBGB0909792.4A GB0909792A GB0909792D0 GB 0909792 D0 GB0909792 D0 GB 0909792D0 GB 0909792 A GB0909792 A GB 0909792A GB 0909792 D0 GB0909792 D0 GB 0909792D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0909792.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Babraham Institute
Original Assignee
Babraham Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Babraham Institute filed Critical Babraham Institute
Priority to GBGB0909792.4A priority Critical patent/GB0909792D0/en
Publication of GB0909792D0 publication Critical patent/GB0909792D0/en
Priority to PCT/GB2010/050957 priority patent/WO2010142981A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0909792.4A 2009-06-08 2009-06-08 Composition and uses thereof Ceased GB0909792D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0909792.4A GB0909792D0 (en) 2009-06-08 2009-06-08 Composition and uses thereof
PCT/GB2010/050957 WO2010142981A2 (en) 2009-06-08 2010-06-08 Composition and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0909792.4A GB0909792D0 (en) 2009-06-08 2009-06-08 Composition and uses thereof

Publications (1)

Publication Number Publication Date
GB0909792D0 true GB0909792D0 (en) 2009-07-22

Family

ID=40937034

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0909792.4A Ceased GB0909792D0 (en) 2009-06-08 2009-06-08 Composition and uses thereof

Country Status (2)

Country Link
GB (1) GB0909792D0 (en)
WO (1) WO2010142981A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106061466A (en) * 2013-12-19 2016-10-26 诺华股份有限公司 Leptin mRNA compositions and formulations

Also Published As

Publication number Publication date
WO2010142981A3 (en) 2012-03-29
WO2010142981A2 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
HUE068042T2 (en) Psma-targeting compounds and uses thereof
IL210804A (en) Benzylidenehydrazides and uses thereof
GB0914644D0 (en) Novel agents and uses thereof
GB0903299D0 (en) Composition and methods
EP2291377A4 (en) Imidazopyrimidinones and uses thereof
IL211204A0 (en) Mucoadherents compositions and their use
ZA201103456B (en) Leukolectins and uses thereof
GB0915796D0 (en) Polymerase compositions and uses
GB0901966D0 (en) Composition
EP2247601A4 (en) Thiazopyrimidinones and uses thereof
EP2490536A4 (en) Compositions and processes
GB0902429D0 (en) Compositions and their use
GB0904941D0 (en) Composition
GB0809912D0 (en) Novel compositions and uses thereof
GB0922389D0 (en) composition
EP2444061A4 (en) Apigenin-containing composition
GB0909768D0 (en) Novel compounds and uses thereof
GB0901494D0 (en) Compositions and Methods
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
GB2461611B (en) Composition and use thereof
GB0902959D0 (en) Composition
GB0909792D0 (en) Composition and uses thereof
GB0905525D0 (en) Compounds and uses
GB0901899D0 (en) Compositions and uses
GB0902812D0 (en) Composition and use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)